Literature DB >> 13018207

Fibrino-peptide.

L LORAND.   

Abstract

Keywords:  FIBRIN; PEPTIDES; THROMBIN/effects

Mesh：

Substances：

Year:  1952        PMID： 13018207      PMCID： PMC1197970          DOI： 10.1042/bj0520200

Source DB:  PubMed          Journal:  Biochem J        ISSN： 0264-6021            Impact factor:   3.857


× No keyword cloud information.
  10 in total

1.  The action of thrombin on fibrinogen.

Authors:  L LORAND; W R MIDDLEBROOK
Journal:  Biochem J       Date:  1952-10       Impact factor: 3.857

2.  The total nitrogen content of egg albumin and other proteins.

Authors:  A C Chibnall; M W Rees; E F Williams
Journal:  Biochem J       Date:  1943-09       Impact factor: 3.857

3.  The nitrogen partition in blood clotting.

Authors:  L B Jaques
Journal:  Biochem J       Date:  1938-07       Impact factor: 3.857

4.  Action of the Venom of Bothrops Atrox on Fibrinogen.

Authors:  B Janszky
Journal:  Science       Date:  1949-09-23       Impact factor: 47.728

5.  The action of thrombin on fibrinogen.

Authors:  K LAKI
Journal:  Science       Date:  1951-10-26       Impact factor: 47.728

6.  'Fibrino-peptide'; new aspects of the fibrinogen-fibrin transformation.

Authors:  L LORAND
Journal:  Nature       Date:  1951-06-16       Impact factor: 49.962

7.  The polymerization of proteins; the action of thrombin on fibrinogen.

Authors:  K LAKI
Journal:  Arch Biochem Biophys       Date:  1951-07       Impact factor: 4.013

8.  Action of thrombin in the clotting of fibrinogen.

Authors:  K BAILEY; F R BETTELHEIM; L LORAND; W R MIDDLEBROOK
Journal:  Nature       Date:  1951-02-10       Impact factor: 49.962

9.  Fibrin clots.

Authors:  L LORAND
Journal:  Nature       Date:  1950-10-21       Impact factor: 49.962

10.  Blood clotting and related processes.

Authors:  T ASTRUP
Journal:  Adv Enzymol Relat Subj Biochem       Date:  1950
  10 in total
  17 in total

1.  Transglutaminase-catalyzed crosslinking of the Aalpha and gamma constituent chains in fibrinogen.

Authors:  S N Murthy; J H Wilson; T J Lukas; Y Veklich; J W Weisel; L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  A pathological inhibitor of fibrin cross-linking.

Authors:  L Lorand; A Jacobsen; J Bruner-Lorand
Journal:  J Clin Invest       Date:  1968-02       Impact factor: 14.808

3.  FIBRINOGEN CLOTTING AND FIBRINO-PEPTIDE FORMATION BY STAPHYLOCOAGULASE AND THE COAGULASE-REACTING FACTOR.

Authors:  M C DRUMMOND; M TAGER
Journal:  J Bacteriol       Date:  1963-03       Impact factor: 3.490

4.  [Transformation forms of fibrinogen].

Authors:  B BLOMBACK; A HENSCHEN
Journal:  Klin Wochenschr       Date:  1963-01-15

5.  Enzymatic activities associated with clotting of fibrinogen by staphylocoagulase and coagulase-reacting factor and their inhibition by disopropylfluophosphate.

Authors:  M C DRUMMOND; M TAGER
Journal:  J Bacteriol       Date:  1962-05       Impact factor: 3.490

6.  Some physicochemical properties of human fibrinogen.

Authors:  E A CASPARY; R A KEKWICK
Journal:  Biochem J       Date:  1957-09       Impact factor: 3.857

7.  [Mechanism of action of heparin as antithrombin and dynamics of fibrin formation].

Authors:  R AMANN; E WERLE
Journal:  Klin Wochenschr       Date:  1957-01-01

8.  Studies on the acetylation of human fibrinogen.

Authors:  E A CASPARY
Journal:  Biochem J       Date:  1956-03       Impact factor: 3.857

9.  The purification of human fibrinogen.

Authors:  R A KEKWICK; M E MACKAY; M H NANCE; B R RECORD
Journal:  Biochem J       Date:  1955-08       Impact factor: 3.857

10.  A double-headed Gly-Pro-Arg-Pro ligand mimics the functions of the E domain of fibrin for promoting the end-to-end crosslinking of gamma chains by factor XIIIa.

Authors:  L Lorand; K N Parameswaran; S N Murthy
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.